BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

774 related articles for article (PubMed ID: 28325537)

  • 1. Midline Extraperitoneal Approach to Retroperitoneal Lymph Node Dissection in Testicular Cancer: Minimizing Surgical Morbidity.
    Syan-Bhanvadia S; Bazargani ST; Clifford TG; Cai J; Miranda G; Daneshmand S
    Eur Urol; 2017 Nov; 72(5):814-820. PubMed ID: 28325537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Robot-assisted Laparoscopic Retroperitoneal Lymph Node Dissection for Testicular Cancer: Evolution of the Technique.
    Stepanian S; Patel M; Porter J
    Eur Urol; 2016 Oct; 70(4):661-667. PubMed ID: 27068395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Midline extraperitoneal approach for retroperitoneal lymph node dissection for testicular germ cell tumor.
    Kim P; Syan-Bhanvadia S; Djaladat H; Faber K; Tadros NN; Nichols C; Daneshmand S
    Urology; 2012 Oct; 80(4):941-5. PubMed ID: 22951007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trans- and extraperitoneal retroperitoneal lymph node dissection (RPLND) in the treatment for nonseminomatous germ cell testicular tumors (NSGCT): a single Chinese center's retrospective analysis.
    Tong S; Chen M; Zu X; Li Y; He W; Lei Y; Liu W; Qi L
    Int Urol Nephrol; 2014 Feb; 46(2):363-9. PubMed ID: 23996573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and Early Oncologic Effectiveness of Primary Robotic Retroperitoneal Lymph Node Dissection for Nonseminomatous Germ Cell Testicular Cancer.
    Pearce SM; Golan S; Gorin MA; Luckenbaugh AN; Williams SB; Ward JF; Montgomery JS; Hafez KS; Weizer AZ; Pierorazio PM; Allaf ME; Eggener SE
    Eur Urol; 2017 Mar; 71(3):476-482. PubMed ID: 27234998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laparoscopic Postchemotherapy Retroperitoneal Lymph-Node Dissection Can Be a Standard Option in Defined Nonseminomatous Germ Cell Tumor Patients.
    Nicolai N; Cattaneo F; Biasoni D; Catanzaro M; Torelli T; Zazzara M; Necchi A; Giannatempo P; Raggi D; Piva L; Colecchia M; Salvioni R; Stagni S
    J Endourol; 2016 Oct; 30(10):1112-1119. PubMed ID: 27533924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical outcome of postchemotherapy retroperitoneal lymph node dissection and predicting retroperitoneal histology in advanced nonseminomatous germ cell tumours of the testis].
    Li XD; Guo SJ; Chen SL; Liu ZF; Dong P; Zhang ZL; Jiang LJ; Yao K; Li YH; Han H; Qin ZK; Liu ZW; Zhou FJ
    Zhonghua Wai Ke Za Zhi; 2017 Aug; 55(8):603-607. PubMed ID: 28789511
    [No Abstract]   [Full Text] [Related]  

  • 8. Long-term oncological outcome after post-chemotherapy retroperitoneal lymph node dissection in men with metastatic nonseminomatous germ cell tumour.
    Fléchon A; Tavernier E; Boyle H; Meeus P; Rivoire M; Droz JP
    BJU Int; 2010 Sep; 106(6):779-85. PubMed ID: 20089110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laparoscopic Retroperitoneal Lymph Node Dissection as a Safe Procedure for Postchemotherapy Residual Mass in Testicular Cancer.
    Faria EF; Neves HS; Dauster B; Machado RD; Magnabosco WJ; Muller RL; Santos AC; Tobias-Machado M
    J Laparoendosc Adv Surg Tech A; 2018 Feb; 28(2):168-173. PubMed ID: 29215949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Robot-assisted post-chemotherapy retroperitoneal lymph node dissection in germ cell tumor: is the single-docking with lateral approach relevant?
    Overs C; Beauval JB; Mourey L; Rischmann P; Soulié M; Roumiguié M; Doumerc N
    World J Urol; 2018 Apr; 36(4):655-661. PubMed ID: 29353314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Efficacy of modified retroperitoneal lymph node dissection for testicular nonseminomatous germ cell tumors].
    Liu ZW; Zhou FJ; Han H; Qin ZK; Yu SL; Li YH; Ye YL; Teng XY
    Ai Zheng; 2008 Dec; 27(12):1302-6. PubMed ID: 19079998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postchemotherapy laparoscopic retroperitoneal lymph node dissection for low-volume, stage II, nonseminomatous germ cell tumor: first 100 patients.
    Steiner H; Leonhartsberger N; Stoehr B; Peschel R; Pichler R
    Eur Urol; 2013 Jun; 63(6):1013-7. PubMed ID: 23021090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minimally invasive post-chemotherapy retroperitoneal lymph node dissection for nonseminoma.
    Sharma P; Sverrisson EF; Zargar-Shoshtari K; Fishman MN; Sexton WJ; Dickinson SI; Spiess PE; Poch MA; Gilbert SM; Pow-Sang JM
    Can J Urol; 2015 Aug; 22(4):7882-9. PubMed ID: 26267026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-chemotherapy laparoscopic retroperitoneal lymph node dissection is feasible for stage IIA/B non-seminoma germ cell tumors.
    Nakamura T; Kawauchi A; Oishi M; Ueda T; Shiraishi T; Nakanishi H; Kamoi K; Naya Y; Hongo F; Okihara K; Miki T
    Int J Clin Oncol; 2016 Aug; 21(4):791-795. PubMed ID: 26701172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extraperitoneal laparoscopic retroperitoneal lymph node dissection after chemotherapy for nonseminomatous testicular germ-cell tumor: surgical and oncological outcomes.
    Arai Y; Kaiho Y; Yamada S; Saito H; Mitsuzuka K; Yamashita S; Namiki S; Nakagawa H; Ishidoya S; Ito A
    Int Urol Nephrol; 2012 Oct; 44(5):1389-95. PubMed ID: 22648291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary robotic RLPND for nonseminomatous germ cell testicular cancer: a two-center analysis of intermediate oncologic and safety outcomes.
    Rocco NR; Stroup SP; Abdul-Muhsin HM; Marshall MT; Santomauro MG; Christman MS; L'Esperance JO; Castle EP
    World J Urol; 2020 Apr; 38(4):859-867. PubMed ID: 31502033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgical Complications in Postchemotherapy Retroperitoneal Lymph Node Dissection for Nonseminoma Germ Cell Tumour: A Population-based Study from the Swedish Norwegian Testicular Cancer Group.
    Gerdtsson A; Håkansson U; Törnblom M; Jancke G; Negaard HFS; Glimelius I; Halvorsen D; Karlsdóttir Á; Haugnes HS; Andreassen KE; Larsen SM; Holmberg G; Wahlqvist R; Tandstad T; Cohn-Cedermark G; Ståhl O; Kjellman A
    Eur Urol Oncol; 2020 Jun; 3(3):382-389. PubMed ID: 31506250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-Chemotherapy Robotic Retroperitoneal Lymph Node Dissection: Institutional Experience.
    Kamel MH; Littlejohn N; Cox M; Eltahawy EA; Davis R
    J Endourol; 2016 May; 30(5):510-9. PubMed ID: 26669219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postchemotherapy laparoscopic retroperitoneal lymph node dissection in nonseminomatous germ-cell tumor.
    Calestroupat JP; Sanchez-Salas R; Cathelineau X; Rozet F; Galiano M; Smyth G; Kasraeian A; Barret E; Vallancien G
    J Endourol; 2009 Apr; 23(4):645-50. PubMed ID: 19335332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modified and bilateral retroperitoneal lymph node dissection for testicular cancer: peri- and postoperative complications and therapeutic outcome.
    Tanaka T; Kitamura H; Kunishima Y; Takahashi S; Takahashi A; Masumori N; Itoh N; Tsukamoto T
    Jpn J Clin Oncol; 2006 Jun; 36(6):381-6. PubMed ID: 16762970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.